Literature DB >> 16611115

Treatment of recurrent epistaxis in HHT.

U W Geisthoff1, M L Fiorella, R Fiorella.   

Abstract

No optimal treatment modality is currently available for the treatment of recurrent epistaxis in HHT. In this review, different therapeutic concepts are discussed together with their pathophysiologic background. Patients often profess a preventive effect for nasal ointments and use packings which can be self-administered in the case of bleeding. An effective first-line treatment for physicians is the endonasal laser coagulation or argon plasma coagulation. A second line surgical procedure is septodermoplasty according to Saunders which can provide long-lasting relief if performed correctly. There have been reports on antifibrinolytic agents and hormones, but their efficacy has yet to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 16611115     DOI: 10.2174/138161206776361255

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

Review 1.  Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

2.  Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.

Authors:  Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-26       Impact factor: 2.503

3.  Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.

Authors:  Holly Boyer; Patricia Fernandes; Chap Le; Bevan Yueh
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-02       Impact factor: 3.858

4.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.

Authors:  Sung Ok Park; Mamta Wankhede; Young Jae Lee; Eun-Jung Choi; Naime Fliess; Se-Woon Choe; Seh-Hoon Oh; Glenn Walter; Mohan K Raizada; Brian S Sorg; S Paul Oh
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

5.  Anesthetic Considerations for a Patient With Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome) Undergoing a Five-Box Thoracoscopic Maze Procedure for Atrial Fibrillation.

Authors:  Dominic Robinson; Barbara Rogers; Ritu Kapoor; Joseph Swan; Gaylynn Speas; Rebecca Gutmann
Journal:  J Investig Med High Impact Case Rep       Date:  2014-10-10

6.  Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia.

Authors:  Urban Geisthoff; Ha-Long Nguyen; Rolf Lefering; Steffen Maune; Kruthika Thangavelu; Freya Droege
Journal:  J Clin Med       Date:  2020-05-17       Impact factor: 4.241

7.  A spinal arteriovenous fistula in a 3-year old boy.

Authors:  Thomas E M Crijnen; Sandra van Gijlswijk; Jozef De Dooy; Maurits H J Voormolen; Dominique Robert; Philippe G Jorens; Jose Ramet
Journal:  Case Rep Pediatr       Date:  2014-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.